---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-030341"
form_type: "8-K"
ticker: "AKTX"
cik: "0001541157"
company_name: "Akari Therapeutics Plc"
filed_at: "2026-06-26T21:15:40+00:00"
generated_at: "2026-06-26T21:18:44.350644+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Akari Therapeutics consolidates remaining private placement closings, issues 980,395 ADSs

## Summary
- Combined second and third closings into single closing on June 26, 2026; issued 980,395 ADSs (or prefunded warrants).
- First closing of 490,193 ADSs occurred May 27, 2026, under the original three-tranche structure.
- Delivery of Series H, I, and J warrants contingent on shareholder approval at June 30, 2026 annual meeting.
- No other changes to the securities purchase agreement besides consolidation of closings.

## SEC filing metadata
- accession: 0001493152-26-030341
- form_type: 8-K
- ticker: AKTX
- cik: 0001541157
- company_name: Akari Therapeutics Plc
- filed_at: 2026-06-26T21:15:40+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/0001493152-26-030341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1541157/000149315226030341/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-030341
- JSON: https://secwatch.observer/filing/0001493152-26-030341.json
- Plain text: https://secwatch.observer/filing/0001493152-26-030341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.